Labcorp Holdings (LH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Labcorp Holdings (LH) is Neutral.

The composite score behind that read is +0.01, weighing +0.14 of bullish evidence against -0.48 bearish.

Labcorp Holdings last closed at $312.15, -0.65% on the session.

Against the IVW growth benchmark the position is -1.45% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

18 graded predictions for LH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Labcorp Holdings in the 34th percentile on valuation and the 64th percentile on return on equity, where 100 is best.

Labcorp Holdings is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $25.48B.

StockMap tracks Labcorp Holdings as the 11th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Labcorp Holdings ranks 41st of 85 in the group, against a group median of +0.00.

Other Health Care stocks

Labcorp Holdings (LH) — StockMap 2-week forecast & tracked accuracy